MHRA publishes position paper clarifying the UK licencing route for microbiome-based medicines, supporting developers to bring these innovative therapies to patients.

Exclusive: As wildfires rage across Europe, Frank Elderson tells the Guardian nature loss poses a growing risk to the global economy

In his first in-depth interview since the theft of UEA emails, the scientist blames inertia and democracy for lack of action